Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction

Caleca L, Catucci I, Figlioli G, De Cecco L, Pesaran T, Ward M, Volorio S, Falanga A, Marchetti M, Iascone M, Tondini C, Zambelli A, Azzollini J, Manoukian S, Radice P, Peterlongo P.

Front Oncol. 2018;8:480.

PUBMED

News

2 July 2024

Simon Noble’s Lecture: Innovation and Engagement in Clinical Research

On Saturday evening, May 18, 2024, after two intensive days of ICTHIC characterized by high-level scientific communications, participants were involved to a special “Noble Session.” On the podium was not a Nobel laureate, but Simon Noble, from Cardiff, UK. Those who regularly attended to the congress already knew that the next 30 minutes would be...
12 October 2023

20 years of scientific progress on cancer and thrombosis: what have we learned?

Our scientific director Anna Falanga and senior researcher Marina Marchetti summarized for the prestigious international journal Journal of Thrombosis and Haemostasis the progress made over the past two decades. Incidence The incidence of venous thrombohemobolism (VTE) is significantly higher (7- to 11-fold), in people with cancer compared to the general population. However, it may...
12 October 2023

DID YOU KNOW THAT ONE OF THE MOST IMPORTANT INTERNATIONAL CONFERENCES ON THROMBOSIS AND CANCER HAS BEEN HELD IN BERGAMO FOR OVER 20 YEARS?

It is called ICTHIC (International Conference on Thrombosis and Hemostasis Issues in Cancer) and it is an international scientific congress that the Artet Foundation helps to organize and, from 2001 to today, it has become a point of reference for the most important world experts on hemostasis and thrombosis in cancer . For professionals...
23 April 2021

ARTET Foundation stand at the 10th International Conference on Cancer, Hemostasis and Thrombosis (ICTHIC – Virtual Edition)

...

Publications 2018

Newsletter subscription